Dysregulated activation of the PI3K/AKT/mTOR signaling pathway affects a wide range of processes, including cell proliferation, metabolism, tumor cell differentiation, autophagy, and epithelial–mesenchymal transition (EMT). This evidence concerns the gene AKT1 and neoplasm.